Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-02-18 @ 10:16 AM
Study NCT ID:
NCT04998032
Status:
COMPLETED
Last Update Posted:
2024-12-06
First Post:
2021-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Sponsor:
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
YN011-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None